Compare COYA & HYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COYA | HYNE |
|---|---|---|
| Founded | 2020 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.7M | 122.6M |
| IPO Year | 2022 | 2025 |
| Metric | COYA | HYNE |
|---|---|---|
| Price | $4.18 | $17.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $15.21 | N/A |
| AVG Volume (30 Days) | ★ 117.7K | 8.0K |
| Earning Date | 11-11-2026 | 11-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,945,753.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $387.14 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 123.57 | N/A |
| 52 Week Low | $3.71 | $13.56 |
| 52 Week High | $6.81 | $17.26 |
| Indicator | COYA | HYNE |
|---|---|---|
| Relative Strength Index (RSI) | 34.38 | 83.29 |
| Support Level | $3.89 | $16.31 |
| Resistance Level | $5.17 | N/A |
| Average True Range (ATR) | 0.29 | 0.18 |
| MACD | -0.07 | 0.07 |
| Stochastic Oscillator | 5.73 | 74.63 |
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
Hoyne Bancorp Inc is a holding company that conducts business mainly through its subsidiaries. It is a savings institution focused on serving customers' banking needs in the market area. The group offers Personal and Business banking services.